Advanced BioDesign as an immunotechnology specialist, provides a tailored and high value solution.
Advanced BioDesign has raised $15.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Advanced BioDesign's investors include Xerys.
Advanced BioDesign is headquartered in Saint Priest, France.
Advanced BioDesign as an immunotechnology specialist, provides a tailored and high value solution.
Advanced BioDesign is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Advanced BioDesign — Funding & Investors." VCBacked, February 2, 2023, https://www.vcbacked.co/company/advanced-biodesign. Accessed August 15, 2026.
VCBacked. (2023). Advanced BioDesign — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/advanced-biodesign
{{cite web |title=Advanced BioDesign — Funding & Investors |url=https://www.vcbacked.co/company/advanced-biodesign |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated